The lab finding does raise the possibility that this new bat virus could spread from animals to humans, researchers said in a ...

Detection of a new coronavirus in bats that enters cells using the same gateway as the virus that causes COVID-19 raises the possibility that it could spread to humans.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

A new coronavirus in bats, similar to that of the virus responsible for Covid-19, has been discovered by researchers at the ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

ISM001-055 was shown to have attenuated cellular senescence through the suppression of various aging processes, thus showing potential as a senomorphic drug.

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

30, 2022. Pfizer bought Biohaven in October 2022. The Pfizer Inc. logo is seen on the lab coat of an employee at the company's research and development facility in Cambridge, Massachusetts.